Skip to content
DMI will discuss the QALY approach and its risks during the next HTAi conference in Tokyo, Japan
Data Mining International will be participating in the symposium arranged by Pfizer during the next HTAi conference in Tokyo, in order to present the risks and inadequacies of the QALY approach used for resource allocations by several countries’ national health reimbursement systems. DMI will also discuss the scientifically more valid and robust alternatives to determine the cost-effectiveness of new medicines and technologies that can be confidently used in place of QALYs.
The information about the HTAi, 10-14 May 2016: